These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2246236)

  • 21. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity.
    Peretz D; Gitay-Goren H; Safran M; Kimmel N; Gospodarowicz D; Neufeld G
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1340-7. PubMed ID: 1540178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
    Kim KJ; Li B; Houck K; Winer J; Ferrara N
    Growth Factors; 1992; 7(1):53-64. PubMed ID: 1380254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.
    Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG
    J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.
    Jakeman LB; Winer J; Bennett GL; Altar CA; Ferrara N
    J Clin Invest; 1992 Jan; 89(1):244-53. PubMed ID: 1729274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and its receptors.
    Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
    Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
    Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
    Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
    Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
    J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
    Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
    J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells.
    Plouët J; Moukadiri H
    J Biol Chem; 1990 Dec; 265(36):22071-4. PubMed ID: 2266109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells.
    Mandriota SJ; Menoud PA; Pepper MS
    J Biol Chem; 1996 May; 271(19):11500-5. PubMed ID: 8626709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
    Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
    J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
    Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E; Schatteman G; Wu T; Kim EA; Varticovski L; Keyt B; Isner JM
    J Clin Invest; 1996 Jan; 97(2):469-76. PubMed ID: 8567969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
    Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
    J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells.
    Wang DS; Miura M; Demura H; Sato K
    Endocrinology; 1997 Jul; 138(7):2953-62. PubMed ID: 9202240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
    Achen MG; Jeltsch M; Kukk E; Mäkinen T; Vitali A; Wilks AF; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):548-53. PubMed ID: 9435229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes.
    Boensch C; Kuo MD; Connolly DT; Huang SS; Huang JS
    J Biol Chem; 1995 Jan; 270(4):1807-16. PubMed ID: 7829517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.